BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs2300478
,
FOXP1
,
Response to oxidative stress
,
HIV infection
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphatidylinositol 3, 5- bisphosphate
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for phosphatidylinositol 3, 5- bisphosphate
Explore Curated Studies Results
Literature
Most Relevant Literature
A PI(3,5)P2 reporter reveals PIKfyve activity and dynamics on macropinosomes and phagosomes.
Molding a PI(3,5)P2 biosensor.
PI(3,5)P2 and NAADP: Team players or lone warriors? - New insights into TPC activation modes.
Rendezvous with PI(3,5)P2 - A rapalog gets caught opening TRPML1.
The second PI(3,5)P2 binding site in the S0 helix of KCNQ1 stabilizes PIP2-at the primary PI1 site w…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus S…
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Met…
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women Wit…
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
Biomarkers in Tissue Samples From Older Women With Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ